Vimarsana
Biggest News Aggregation in the World

Page 11 - Polypid Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Polypid Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Polypid Ltd Today - Breaking & Trending Today

Nasdaq Jumps Over 100 Points; Crude Oil Rises Sharply - Vimarsana News

Nasdaq Jumps Over 100 Points; Crude Oil Rises Sharply

U.S. stocks extended gains midway through trading on Friday, following the release of jobs report for August. The Dow traded up 0.85% to 31,924.1...

PolyPid Announces Presentation at the 2022 Military Health - Vimarsana News

PolyPid Announces Presentation at the 2022 Military Health

Efficacy Data of D-PLEX100 in reduction of Surgical Site Infection in Surgical Trauma Injuries will be Presented During a Podium Presentation PETACH...

PolyPid Ltd. (PYPD) CEO Dikla Czaczkes Akselbrad on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

PolyPid Ltd. (PYPD) CEO Dikla Czaczkes Akselbrad on Q2 2022 Results - Earnings Call Transcript

PolyPid Ltd. (NASDAQ:NASDAQ:PYPD) Q2 2022 Results Conference Call August 10, 2022 08:30 AM ET Company Participants Bob Yedid - IR, LifeSci Advisors Dikla Czaczkes Akselbrad - CEO Ori...

PolyPid Announces Exclusive Licensing Agreement with ADVANZ PHARMA for the Commercialization of D-PLEX₁₀₀ in Europe - Vimarsana News

PolyPid Announces Exclusive Licensing Agreement with ADVANZ PHARMA for the Commercialization of D-PLEX₁₀₀ in Europe

03.08.2022 - PolyPid to potentially receive over $110 million in upfront and milestone payments as well as royalties on net sales ADVANZ PHARMA to receive exclusive rights to commercialize D-PLEX100 for the prevention of surgical site infections in ... Seite 1

PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO - Vimarsana News

PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO

05.07.2022 - Company Previously Announced Planned CEO Transition Following Retirement of Amir WeisbergPETACH TIKVA, Israel, July 05, 2022 (GLOBE NEWSWIRE) - PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to ... Seite 1